While Novo Nordisk & Eli Lilly pass the blame to PBMs, we are getting raped by pharma, middlemen & corporate greed. The cost of #Ozempic in China is $193 vs US $1350. Perhaps eliminating diabetes, heart disease, & chronic obesity just isn’t as lucrative as lifetime medicating a fat & unhealthy U.S?
November 29, 2024 at 10:48 PM
While Novo Nordisk & Eli Lilly pass the blame to PBMs, we are getting raped by pharma, middlemen & corporate greed. The cost of #Ozempic in China is $193 vs US $1350. Perhaps eliminating diabetes, heart disease, & chronic obesity just isn’t as lucrative as lifetime medicating a fat & unhealthy U.S?
Every week, I see a new study talking about this or that effect of GLP-1 receptor agonists like #ozempic. FINALLY, we have a study evaluating all the outcomes (good and bad) in one dataset. There are some... surprises. 🧵
January 22, 2025 at 9:33 PM
Every week, I see a new study talking about this or that effect of GLP-1 receptor agonists like #ozempic. FINALLY, we have a study evaluating all the outcomes (good and bad) in one dataset. There are some... surprises. 🧵
Really proud to start the year by sharing our new review in @endosocjournals.bsky.social on the roles of GLP-1 in eating and obesity treatment, led by superstar postdoc @laurenjonesucl.bsky.social!
academic.oup.com/endo/article...
🧪🧠📈 #neuroscience #neuroskyence #GLP-1 #obesity #wegovy #ozempic
academic.oup.com/endo/article...
🧪🧠📈 #neuroscience #neuroskyence #GLP-1 #obesity #wegovy #ozempic
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Abstract. Obesity is now considered a chronic relapsing progressive disease, associated with increased all-cause mortality that scales with body weight, af
academic.oup.com
January 21, 2025 at 11:59 AM
Really proud to start the year by sharing our new review in @endosocjournals.bsky.social on the roles of GLP-1 in eating and obesity treatment, led by superstar postdoc @laurenjonesucl.bsky.social!
academic.oup.com/endo/article...
🧪🧠📈 #neuroscience #neuroskyence #GLP-1 #obesity #wegovy #ozempic
academic.oup.com/endo/article...
🧪🧠📈 #neuroscience #neuroskyence #GLP-1 #obesity #wegovy #ozempic
#Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
www.sciencealert.com/ozempic-riva...
www.sciencealert.com/ozempic-riva...
Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
A flight of stairs can become a challenge for aching knees.
www.sciencealert.com
October 3, 2026 at 11:40 AM
#Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
www.sciencealert.com/ozempic-riva...
www.sciencealert.com/ozempic-riva...
Everyone is talking about #Ozempic #Wegovy which are agonists of the GLP-1 receptor. For more about this receptor and its physiological role, see the quickguide by Michael Krashes in our latest issue
www.cell.com/current-biol...
www.cell.com/current-biol...
Glucagon-like peptide-1 receptor
Michael Krashes discusses glucagon-like peptide-1 receptors, their physiological role
in glucose metabolism and the mode of action of their agonists that are used to treat
obesity and were later shown...
www.cell.com
December 3, 2024 at 7:38 PM
Everyone is talking about #Ozempic #Wegovy which are agonists of the GLP-1 receptor. For more about this receptor and its physiological role, see the quickguide by Michael Krashes in our latest issue
www.cell.com/current-biol...
www.cell.com/current-biol...
October 3, 2025 at 4:16 PM
«L’obésité est une maladie de pauvres dont un traitement efficace n’est accessible qu’aux riches» :
#Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé.
Des médecins prescrivent son anti-diabétique, l’ #Ozempic, aux moins riches.
Enquête sur ce système D.
www.mediapart.fr/journal/fran...
#Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé.
Des médecins prescrivent son anti-diabétique, l’ #Ozempic, aux moins riches.
Enquête sur ce système D.
www.mediapart.fr/journal/fran...
Obésité : ces médecins qui rusent pour soigner les moins aisés
Le médicament anti-obésité Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé en France alors que la maladie touche davantage les populations précaires. Des médecins prescrivent son traitement…
www.mediapart.fr
September 15, 2025 at 1:26 PM
«L’obésité est une maladie de pauvres dont un traitement efficace n’est accessible qu’aux riches» :
#Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé.
Des médecins prescrivent son anti-diabétique, l’ #Ozempic, aux moins riches.
Enquête sur ce système D.
www.mediapart.fr/journal/fran...
#Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé.
Des médecins prescrivent son anti-diabétique, l’ #Ozempic, aux moins riches.
Enquête sur ce système D.
www.mediapart.fr/journal/fran...
I’ve been on #Ozempic for two months now. Was diagnosed as pre-diabetic. So having it to lower blood sugar. Has worked well and, as a side effect, I’ve lost 5-6kg. Some vomiting which was unpleasant. Huge appetite suppressant so eating small amounts. Dad died from diabetes at 65. I am 60.
July 15, 2025 at 9:37 PM
I’ve been on #Ozempic for two months now. Was diagnosed as pre-diabetic. So having it to lower blood sugar. Has worked well and, as a side effect, I’ve lost 5-6kg. Some vomiting which was unpleasant. Huge appetite suppressant so eating small amounts. Dad died from diabetes at 65. I am 60.
Kaum ein Wirkstoff ist derzeit so populär wie #Semaglutid #Ozempic Arzneimittelfälscher wittern das große Geld und bringen Spritzen in Umlauf, die statt Semaglutid Insulin enthalten. Diese Fälschungen kosteten in Österreich mehreren Menschen fast das Leben: medwatch.de/arzneimittel...
November 18, 2023 at 4:06 PM
Kaum ein Wirkstoff ist derzeit so populär wie #Semaglutid #Ozempic Arzneimittelfälscher wittern das große Geld und bringen Spritzen in Umlauf, die statt Semaglutid Insulin enthalten. Diese Fälschungen kosteten in Österreich mehreren Menschen fast das Leben: medwatch.de/arzneimittel...
February 25, 2025 at 10:32 PM
Canadian scientist Daniel Drucker of the University of Toronto and Sinai Health wins Breakthrough Prize for discovery of GLP-1 hormone used in #Ozempic, #Mounjaro www.ctvnews.ca/sci-tech/art... via @ctvnews-rss.bsky.social @jwoodgett.bsky.social #WeightLoss #diabetes
Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro — that have...
www.ctvnews.ca
April 6, 2025 at 8:59 PM
Canadian scientist Daniel Drucker of the University of Toronto and Sinai Health wins Breakthrough Prize for discovery of GLP-1 hormone used in #Ozempic, #Mounjaro www.ctvnews.ca/sci-tech/art... via @ctvnews-rss.bsky.social @jwoodgett.bsky.social #WeightLoss #diabetes
My #Ozempic journey continues. Month 3. Have lost a stone. Jeans falling off me. Nearly mooned Dublin commuters this morning as I made my way to the dentist. apologies.
August 12, 2025 at 10:03 PM
My #Ozempic journey continues. Month 3. Have lost a stone. Jeans falling off me. Nearly mooned Dublin commuters this morning as I made my way to the dentist. apologies.
On this week’s @butthonestlypod.bsky.social we talk about my adventures at a sex/ pool party, we take your questions about throat STIs and prevention, we give the truth about #Ozempic #Dick , we give a Trampage update and read your dirty confessions!
podcasts.apple.com/us/podcast/b...
podcasts.apple.com/us/podcast/b...
June 25, 2025 at 4:17 PM
On this week’s @butthonestlypod.bsky.social we talk about my adventures at a sex/ pool party, we take your questions about throat STIs and prevention, we give the truth about #Ozempic #Dick , we give a Trampage update and read your dirty confessions!
podcasts.apple.com/us/podcast/b...
podcasts.apple.com/us/podcast/b...
💥IS THE SKY THE LIMIT? OZEMPIC AND GLP-1 DRUGS LOWER THE RISK OF 42 HEALTH CONDITIONS, including heart attacks, strokes & Alzheimer’s, per a HUGE new study.💥 Sharing my new piece👇
fortune.com/well/article... #ozempic #glp1 #BlueSky #MedSky 🧪 #IDSky #scisky #medtwitter #EMSky #EMedSky
fortune.com/well/article... #ozempic #glp1 #BlueSky #MedSky 🧪 #IDSky #scisky #medtwitter #EMSky #EMedSky
Huge Ozempic and GLP-1 drug study finds they may lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
Drugs like Ozempic may reduce risks in dozens of health outcomes, including heart attacks and Alzheimer’s disease.
fortune.com
January 20, 2025 at 4:26 PM
💥IS THE SKY THE LIMIT? OZEMPIC AND GLP-1 DRUGS LOWER THE RISK OF 42 HEALTH CONDITIONS, including heart attacks, strokes & Alzheimer’s, per a HUGE new study.💥 Sharing my new piece👇
fortune.com/well/article... #ozempic #glp1 #BlueSky #MedSky 🧪 #IDSky #scisky #medtwitter #EMSky #EMedSky
fortune.com/well/article... #ozempic #glp1 #BlueSky #MedSky 🧪 #IDSky #scisky #medtwitter #EMSky #EMedSky
Russell Crowe stunned fans with a notably slimmer look at the Golden Bee Awards in Malta.
Fans speculate Crowe used Ozempic, but a source credits his weight loss to clean eating and workouts.
#RussellCrowe
#GoldenBeeAwards
#Ozempic
Fans speculate Crowe used Ozempic, but a source credits his weight loss to clean eating and workouts.
#RussellCrowe
#GoldenBeeAwards
#Ozempic
“Ozempic Time!”: Russell Crowe Stuns With Dramatic Weight Loss During Recent Outing
He finally got on Ozempic, and he really needed it.
www.boredpanda.com
July 2, 2025 at 3:34 AM
Russell Crowe stunned fans with a notably slimmer look at the Golden Bee Awards in Malta.
Fans speculate Crowe used Ozempic, but a source credits his weight loss to clean eating and workouts.
#RussellCrowe
#GoldenBeeAwards
#Ozempic
Fans speculate Crowe used Ozempic, but a source credits his weight loss to clean eating and workouts.
#RussellCrowe
#GoldenBeeAwards
#Ozempic
Farmaceut #EliLilly gaat zich waarschijnlijk in #Katwijk vestigen, pal aan het #Valkenburgsemeer. Veel Katwijkers morren maar de miljarden-procedure heeft te veel haast voor een #referendum. En dat voor #afslankpillen.
#valkenburg #leiden #BioSciencePark #mounjaro #ozempic @leidschdagblad.nl
#valkenburg #leiden #BioSciencePark #mounjaro #ozempic @leidschdagblad.nl
October 3, 2026 at 8:52 AM
Farmaceut #EliLilly gaat zich waarschijnlijk in #Katwijk vestigen, pal aan het #Valkenburgsemeer. Veel Katwijkers morren maar de miljarden-procedure heeft te veel haast voor een #referendum. En dat voor #afslankpillen.
#valkenburg #leiden #BioSciencePark #mounjaro #ozempic @leidschdagblad.nl
#valkenburg #leiden #BioSciencePark #mounjaro #ozempic @leidschdagblad.nl
#Tiktok wont post my rant about how fatphobia has led y’all to use #Ozempic and now people are developing #disabilities from Ozempic use sooo here you go Bluesky:
January 12, 2026 at 9:06 PM
#Tiktok wont post my rant about how fatphobia has led y’all to use #Ozempic and now people are developing #disabilities from Ozempic use sooo here you go Bluesky:
Why #Ozempic should be covered by medicare for #WeightLoss, not just #diabetes treatment, by @drlabos.bsky.social montrealgazette.com/opinion/colu... via @mtlgazette.bsky.social
Christopher Labos: Why Ozempic should be covered by medicare for weight loss
Recent studies reinforce that weight loss is not simply an esthetic consideration. It has very real benefits in terms of preventing disease.
montrealgazette.com
November 15, 2024 at 4:24 PM
Why #Ozempic should be covered by medicare for #WeightLoss, not just #diabetes treatment, by @drlabos.bsky.social montrealgazette.com/opinion/colu... via @mtlgazette.bsky.social
Our article examining the effects of chronic #GLP-1 receptor agonist (#semaglutide #ozempic) treatment on the incentive motivational value of a small #food reward and the cue that predicts it is now out in Psychopharmacology.
Open access article 👇
link.springer.com/10.1007/s002...
Open access article 👇
link.springer.com/10.1007/s002...
Excited to share our new GLP-1 receptor agonist study! Chronic semaglutide potentiates motivation for small food rewards and associated cues, but reduces intake when food is freely available—surprising twist! #GLP-1, #behavior #neuroscience #pharmacology 1/
🔗 www.biorxiv.org/cgi/content/...
🔗 www.biorxiv.org/cgi/content/...
Chronic semaglutide treatment enhances the incentive motivational value of a small food reward and associated cue in male and female rats
Rationale: Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, are increasingly utilized in clinical practice due to their efficacy in promoting sustained weight loss following chr...
www.biorxiv.org
March 23, 2026 at 12:10 PM
Our article examining the effects of chronic #GLP-1 receptor agonist (#semaglutide #ozempic) treatment on the incentive motivational value of a small #food reward and the cue that predicts it is now out in Psychopharmacology.
Open access article 👇
link.springer.com/10.1007/s002...
Open access article 👇
link.springer.com/10.1007/s002...
GLP-1 drugs like #Ozempic may lower the risk of 42 health conditions, including Alzheimer's, dementia, and substance use disorders—but raise risks for 19 others. A doctor-scientist explains the latest study: https://buff.ly/4awsQBa (@zalaly.bsky.social, Washington University in St. Louis) 🩺
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
buff.ly
January 22, 2025 at 10:36 PM
GLP-1 drugs like #Ozempic may lower the risk of 42 health conditions, including Alzheimer's, dementia, and substance use disorders—but raise risks for 19 others. A doctor-scientist explains the latest study: https://buff.ly/4awsQBa (@zalaly.bsky.social, Washington University in St. Louis) 🩺